EP
MRK icon

Eudaimonia Partners’s Merck MRK Stock Holding History

Eudaimonia Partners’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$794K Buy
6,020
+51
+0.9% +$6.29K 0.19% 122
2023
Q4 		$651K Sell
5,969
-8,839
-60% -$918K 0.17% 125
2023
Q3 		$1.52M Sell
14,808
-18
-0.1% -$1.94K 0.37% 61
2023
Q2 		$1.71M Buy
14,826
+616
+4% +$69.9K 0.38% 61
2023
Q1 		$1.51M Sell
14,210
-598
-4% -$64.6K 0.36% 63
2022
Q4 		$1.64M Sell
14,808
-2,057
-12% -$210K 0.4% 63
2022
Q3 		$1.45M Sell
16,865
-8,710
-34% -$778K 0.38% 65
2022
Q2 		$2.33M Buy
25,575
+2,187
+9% +$194K 0.43% 62
2022
Q1 		$1.92M Buy
+23,388
New +$1.84M 0.33% 84
2021
Q3 		$1.75M Sell
23,247
-183
-0.8% -$13.9K 0.32% 92
2021
Q2 		$1.82M Buy
23,430
+1,269
+6% +$94.4K 0.34% 89
2021
Q1 		$1.63M Sell
22,161
-1,862
-8% -$137K 0.34% 78
2020
Q4 		$1.88M Sell
24,023
-649
-3% -$49.6K 0.42% 59
2020
Q3 		$1.95M Buy
24,672
+2,248
+10% +$176K 0.5% 51
2020
Q2 		$1.65M Sell
22,424
-912
-4% -$68.7K 0.63% 36
2020
Q1 		$1.71M Buy
23,336
+3,933
+20% +$309K 0.75% 33
2019
Q4 		$1.68M Buy
+19,403
New +$1.59M 0.67% 35

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Eudaimonia Partners's MRK Position: Q1 2024 in Review

Eudaimonia Partners increased its Merck (MRK) stake by 0.85% in Q1 2024, buying an estimated $6.29K and bringing the position to 6,020 shares worth $794K. The position accounts for 0.19% of the portfolio, ranked #122.

Eudaimonia Partners first reported a position in MRK in Q4 2019 and has held it in 17 quarters since. The position peaked at $2.33M in Q2 2022. 3,535 funds tracked by Wall St. Rank hold MRK as of Q1 2024.

  • Eudaimonia Partners held 6,020 shares of Merck worth $794K as of Q1 2024.
  • Eudaimonia Partners bought 51 Merck shares in Q1 2024, an estimated $6.29K.
  • Merck made up 0.19% of Eudaimonia Partners's portfolio in Q1 2024, its #122 holding.
  • Eudaimonia Partners first reported a position in Merck in Q4 2019 and has held it in 17 quarters since.
  • Eudaimonia Partners's Merck position peaked at $2.33M in Q2 2022.
  • 3,535 funds tracked by Wall St. Rank held Merck as of Q1 2024.

Based on Eudaimonia Partners's 13F filing for Q1 2024, filed 25 Apr 2024.